Stay updated on Pembrolizumab for ALL MRD Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab for ALL MRD Clinical Trial page.

Latest updates to the Pembrolizumab for ALL MRD Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedA minor platform revision updated the page from v3.6.2 to v3.6.3, indicating behind-the-scenes changes to the site's code or rendering without altering displayed study information.SummaryDifference0.1%

- Check17 days agoChange DetectedThe page revision tag was updated to v3.6.2, replacing the previous v3.6.0.SummaryDifference0.1%

- Check31 days agoChange DetectedRecruitment status on the study page is updated to indicate no further participant enrollment ('No longer looking for participants'), and several new navigation/help sections are added (How to Read a Study Record, Common Questions, How to Join a Study). A minor formatting change to the Intervention/Treatment heading and a new revision stamp 'Revision: v3.6.0' are also included.SummaryDifference0.5%

- Check39 days agoChange DetectedThe footer now shows Revision: v3.5.5, replacing the previous Revision: v3.5.4. This indicates a system or site-wide update to the platform.SummaryDifference0.1%

- Check60 days agoChange DetectedThe revision label was updated from v3.5.3 to v3.5.4, indicating a deployment or maintenance update to the site. There is no visible change to study content or user-facing features on this page.SummaryDifference0.1%

- Check81 days agoChange DetectedThe page’s footer revision/version has been updated from v3.5.2 to v3.5.3, reflecting a site/platform release rather than any change to the clinical trial details.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab for ALL MRD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for ALL MRD Clinical Trial page.